AIΩMEGA™

Mission: Focus on invention, innovation and market execution of products and methods aimed at reaching complex unmet needs while expanding the frontiers of medicine, biotechnology, nanotechnology and pharmacotherapeutics. 

Bring disruptive technology and products to the world market. Our strategy is simplicity in diversity aimed at global reach to fulfill unmet needs. 

AIΩMEGA™ first product, AIΩ1, is ready to go to market to improve athletic performance (speed, stamina, endurance, accuracy).
AIΩ1 will protect athletes and the military personnel from concussion related TBI (Traumatic Brain Injury), CTE (Chronic Traumatic Encephalopathy) and hypoxic brain and heart damage.
AIΩ1 and its complimentary predictive algorithms will facilitate weight loss programs and fitness programs while promoting restorative sleep as well.
LANETEA (Laser Assisted Nanotech Endovascular Trans-Endothelial Atherolysis) brings an array of designs of balloon catheters, nanotechnology catheters and Laser catheters. These devices will hybridize human skill with robotics and machine learning to provide a new and innovative method for restoration of normal arterial luminal cross-sectional area. These procedures and technologies are the first of their kind that remove lipid-laden plaque from any accessible artery using 'Microvascular Atherolysis' without fear of plaque-rupture, acute thrombosis, widespread damage to endothelium or vascular recoil. Since vascular recoil is prevented, there is no need to deploy a stent. Stent-related complications such as re-endothelization, neo-intimal hyperplasia, early and late stenosis or thrombosis are thus avoided. Normal artery elasticity is restored. Patient's will be able to perform higher intensity of athletic activities as the vessel is not subject to stent-related stiffness or lumen cross-section limitation. 

We provide integrated customized solutions to restore health,  enhance athletic performance and maximize opportunities through innovation to make the Universe  a better place for you.